Refined pharmacophore features for virtual screening of human thromboxane A2 receptor antagonists

For a long time, the structural basis of TXA2 receptor is limited due to the lack of crystal structure information, till the release of the crystal structure of TXA2 receptor, which deepens our understanding about ligand recognition and selectivity mechanisms of this physiologically important receptor. In this research, we report the successful implementation in the discovery of an optimal pharmacophore model of human TXA2 receptor antagonists through virtual screening. Structure-based pharmacophore models were generated based on two crystal structures of human TXA2 receptor (PDB entry 6IIU and 6IIV). Docking simulation revealed interaction modes of the virtual screening hits against TXA2 receptor, which was validated through molecular dynamics simulation and binding free energy calculation. ADMET properties were also analyzed to evaluate the toxicity and physio-chemical characteristics of the hits. The research would provide valuable insight into the binding mechanisms of TXA2 receptor antagonists and thus be helpful for designing novel antagonists.

[1]  G. Kocic,et al.  Benzimidazoles as novel deoxyribonuclease I inhibitors , 2018, Journal of cellular biochemistry.

[2]  Abdeslam Asehraou,et al.  In vitro screening, homology modeling and molecular docking studies of some pyrazole and imidazole derivatives. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  John J. Irwin,et al.  ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..

[4]  Huanxiang Liu,et al.  Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity , 2018, Proteins.

[5]  A. Tyagi,et al.  Identification of Mycobacterium tuberculosis BioA inhibitors by using structure-based virtual screening , 2018, Drug design, development and therapy.

[6]  Giuseppe Floresta,et al.  Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands. , 2017, European journal of medicinal chemistry.

[7]  Hui Zhang,et al.  Structural basis for ligand recognition of the human thromboxane A2 receptor , 2018, Nature Chemical Biology.

[8]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[9]  Luis G Valerio,et al.  In silico toxicology for the pharmaceutical sciences. , 2009, Toxicology and applied pharmacology.

[10]  J. Hildebrandt,et al.  Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin. , 1983, The Journal of clinical investigation.

[11]  James Scott-Brown,et al.  Visualization and analysis of non-covalent contacts using the Protein Contacts Atlas , 2018, Nature structural & molecular biology.

[12]  Hai Pham-The,et al.  Computational modeling of human oral bioavailability: what will be next? , 2018, Expert opinion on drug discovery.

[13]  Dev Bukhsh Singh,et al.  Identification of potential inhibitors of Fasciola gigantica thioredoxin1: computational screening, molecular dynamics simulation, and binding free energy studies , 2018, Journal of biomolecular structure & dynamics.

[14]  Jinn-Moon Yang,et al.  GEMDOCK: A generic evolutionary method for molecular docking , 2004, Proteins.

[15]  Douglas E. V. Pires,et al.  pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.

[16]  Thierry Langer,et al.  LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..

[17]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[18]  A. Elfiky,et al.  Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures , 2018, SAR and QSAR in environmental research.

[19]  Yohan Park,et al.  Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies , 2019, Comput. Biol. Chem..

[20]  Zhi Jing,et al.  Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations , 2019, Comput. Biol. Chem..

[21]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[22]  Stefan Frantz,et al.  Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane‐mediated thromboxane A2 receptor activation , 2014, British journal of pharmacology.

[23]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[24]  Daniela Schuster,et al.  Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation , 2011, Bioorganic & medicinal chemistry.

[25]  Muthukumaran Sivashanmugam,et al.  Virtual screening of natural inhibitors targeting ornithine decarboxylase with pharmacophore scaffolding of DFMO and validation by molecular dynamics simulation studies , 2019, Journal of biomolecular structure & dynamics.